Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Eravacycline (TP-434) is active in vitro against biofilms formed by uropathogenic Escherichia coli.

Grossman TH, O'Brien W, Kerstein KO, Sutcliffe JA.

Antimicrob Agents Chemother. 2015 Apr;59(4):2446-9. doi: 10.1128/AAC.04967-14. Epub 2015 Jan 26.

2.

Dual role of CcpC protein in regulation of aconitase gene expression in Listeria monocytogenes and Bacillus subtilis.

Mittal M, Pechter KB, Picossi S, Kim HJ, Kerstein KO, Sonenshein AL.

Microbiology. 2013 Jan;159(Pt 1):68-76. doi: 10.1099/mic.0.063388-0. Epub 2012 Nov 8.

3.

Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice.

Amuguni JH, Lee S, Kerstein KO, Brown DW, Belitsky BR, Herrmann JE, Keusch GT, Sonenshein AL, Tzipori S.

Vaccine. 2011 Jun 24;29(29-30):4778-84. doi: 10.1016/j.vaccine.2011.04.083. Epub 2011 May 10.

PMID:
21565244
4.

Development of a Bacillus subtilis-based rotavirus vaccine.

Lee S, Belitsky BR, Brinker JP, Kerstein KO, Brown DW, Clements JD, Keusch GT, Tzipori S, Sonenshein AL, Herrmann JE.

Clin Vaccine Immunol. 2010 Nov;17(11):1647-55. doi: 10.1128/CVI.00135-10. Epub 2010 Sep 1.

5.

Efficacy, heat stability and safety of intranasally administered Bacillus subtilis spore or vegetative cell vaccines expressing tetanus toxin fragment C.

Lee S, Belitsky BR, Brown DW, Brinker JP, Kerstein KO, Herrmann JE, Keusch GT, Sonenshein AL, Tzipori S.

Vaccine. 2010 Sep 24;28(41):6658-65. doi: 10.1016/j.vaccine.2010.08.016. Epub 2010 Aug 13.

PMID:
20709005

Supplemental Content

Loading ...
Support Center